en · de · es · pt
bench-notes.peptides6579.com › Info › Bremelanotide Naming And Background — Hands-On Walkthrough

Bremelanotide Naming And Background — Hands-On Walkthrough

By Editorial Desk · published 2025-08-02 · last reviewed 2025-09-20 · Info

The short version of reversed-phase HPLC fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2025-09-20 and is reviewed periodically as new material appears.

Bremelanotide Naming and Background

Bremelanotide is a synthetic cyclic heptapeptide developed under the research code PT-141. The code reflects its position in an internal compound series rather than a chemical classification, and the name bremelanotide was later adopted for regulatory filings. Structurally it belongs to the melanocortin peptide family and shares a core sequence motif with alpha-melanocyte-stimulating hormone. The compound is supplied as an acetate salt in aqueous solution for injection. In reference literature it is indexed under both the code and the generic name, a dual listing that can complicate database searches.

Early work on melanocortin analogs in the 1980s and 1990s produced peptides intended to influence pigmentation and appetite. One of these, melanotan II, was observed to affect sexual desire as an incidental finding in self-administration reports. Researchers then pursued analogs with altered receptor selectivity and improved handling characteristics, and PT-141 emerged from that program in the late 1990s. The development path moved from dermatology and metabolism toward a central nervous system application, a shift that shaped both trial designs and the eventual label.

Regulatory review of bremelanotide concluded in 2019 with approval in the United States for a defined indication in premenopausal women. The reviewed formulation is a single-use prefilled autoinjector given subcutaneously, and its label carries cardiovascular monitoring language tied to blood pressure changes recorded during trials. Availability outside the approving jurisdiction varies, and in several countries the compound remains unapproved or is handled as a prescription-only item. Compounded and research-grade material also circulates, and it differs from the reviewed product in purity, characterization, and chain of custody.

Peptide Handling and Storage Practice

Lyophilized peptide material is generally stored at -20 °C or below to limit degradation, while reconstituted solutions are less stable and are typically kept refrigerated and protected from light. Repeated freeze-thaw cycles can accelerate aggregation and should be minimized. Stability for any specific lot depends on purity, moisture content, and packaging. Handling in a temperature-controlled environment reduces variability across replicates, and exposure to ambient humidity during weighing can introduce error. Aliquotting reduces the number of times a stock container is opened.

Reverse-phase high-performance liquid chromatography is the standard method for assessing purity. Mass spectrometry confirms molecular identity and detects sequence variants or truncation products. Ultraviolet absorbance at 214 or 280 nm is used for quantification, with the choice depending on the peptide sequence. Method validation typically addresses linearity, limit of detection, and precision across a defined concentration range. Impurity profiling may also employ ion-exchange or size-exclusion chromatography, and these techniques complement one another.

Certificate of analysis documents usually report purity percentage, molecular weight, and appearance. Researchers verify identity by comparing observed and theoretical mass values. Chain-of-custody records and batch numbers help trace material from source to experiment. Independent verification of supplier claims is considered good practice when material identity is critical to a study. Records should include the storage history of each aliquot, and unexpected deviations in appearance or solubility warrant re-testing before use.

Pt-141 at a glance

PropertyValueNotes
Molecular formulaC50H68N14O10Cyclic heptapeptide core
Molecular weight1025.2 g/molCalculated for the free base
CAS registry number189691-06-3Free base; the acetate salt has a separate entry
Solubility classWater-solubleFreely soluble in aqueous media near neutral pH
Typical storage2 to 8 °CProtect from light; avoid repeated freeze-thaw cycles

Analytical Methods and Storage Practice

The lactam ring that closes the peptide backbone improves resistance to exopeptidase attack, but the molecule stays susceptible to hydrolysis and oxidation once dissolved. Degradation accelerates with temperature, extreme pH, and light exposure, and repeated freeze-thaw cycles promote aggregation and material loss. Lyophilized powder held desiccated at or below minus twenty degrees Celsius is the common way to keep reference material. Reconstituted solutions are generally kept cold and used within a short window because their stability is far lower than that of the dry solid.

Handling procedures emphasize minimizing moisture uptake, since the dried solid is hygroscopic and can draw water when warmed to room temperature before a vial is opened. Laboratories record lot number, purity, counter-ion content, and residual solvent data supplied by the producer. Impurity profiles are compared run to run, and any shift in retention time or peak shape prompts re-verification against a reference standard. Certificates of analysis are treated as claims to be checked rather than accepted at face value.

Related pages on this site

Supporting material

Additionally, operating these two-stage systems under thermophilic conditions (55 °C) has been validated as a robust strategy for full-scale applications, allowing for higher organic loading rates and optimized energy recovery compared to single-stage configurations.

They were, collectively, a very representative group: two engineers, two chemists, two biologists, one representative of agricultural science, one geologist, one representative of veterinary science, one representative of manufacturing industries, and one representative of the agricultural and pastoral industries. Robertson attended the Council's first official meeting, in Melbourne, on 22 June 1926, as the acting chairman of the South Australian Committee.

The industry was expected to invest US$7.1 billion in integrated resorts (US$3.5 billion in Marina Bay; US$3.6 billion in Resorts World). In 2008, the CRA was formed to regulate gambling in management and operation of the casinos in Singapore. It was reconstituted to form the GRA in 2022. On 20 July 2017, the Ministry of Home Affairs announced that regulations on slot machines would be tightened over the next two years and included changes that added more stringent criteria to meet for permits, requirements aimed at reducing availability and accessibility, and setting in place social safeguards to mitigate potential problem gambling. In 2018, the newly formed Singapore Premier League (SPL), known previously as S.League, disallowed non-SPL clubs to have slot machines while SPL clubs to have a maximum of 15 machines, by the end of 2019. On 15 September 2022, SPL clubs were informed to stop all jackpot operations by the end of October.

Sources: en.wikipedia.org

Supporting material

=== BBC Question Time appearance === On 5 February 2015, Galloway appeared on BBC's Question Time discussion programme, recorded in Finchley, London, within a constituency with Britain's largest Jewish community. The Jewish Chronicle wrote that "Galloway was heckled by Jewish audience members who challenged him on his anti-Israel record" and the audience shouted "You're not welcome here". Five days later, Hadley Freeman, a columnist for The Guardian, tweeted: "Galloway has said and done things that cross the line from anti-Israel to antisemitic". Galloway said that he would issue a suit for defamation against her. Freeman then deleted the tweet. Some who had re-tweeted Freeman's comment were then sent a letter from Chambers Solicitors, acting for Galloway, asking for an apology and £5,000 plus Value Added Tax (then levied at 20%) to cover costs incurred by the letter. Some people who received the letter complained to the Solicitors Regulation Authority. Eric Heinze, Professor of Law at Queen Mary University of London, noted that an editor of the Media Lens website had sent a tweet to Freeman asking if she could provide evidence for her claim that Galloway is antisemitic. Heinze wrote that "any example she could cite would probably persuade some and not others. Even if an overwhelming majority were unpersuaded, a highly popular opinion does not create an objectively verifiable fact." Chambers Solicitors' conduct was the subject of a warning from the SRA a year later. Initiating a libel action must begin within a year and no formal writ was issued.

=== Sample preparation === Conducting and semi-conducting samples may be directly analyzed after being formed into electrodes. Non-conductive samples are first powdered, mixed with a conducting powder (usually high purity graphite or silver), homogenized, and then formed into electrodes. Even liquids can be analyzed if they are frozen or after impregnating a conducting powder. Sample homogeneity is important for reproducibility.

=== By country === List of submarine operators Australia – Collins-class submarine Bangladesh – Submarines of the Bangladesh Navy China – Submarines of the People's Liberation Army Navy France – Submarines in the French Navy, List of submarines of the French Navy, List of French submarine classes and types Germany – List of U-boats of Germany India – Submarines of the Indian Navy Israel – Dolphin-class submarine Japan – Imperial Japanese Navy submarines, List of combatant ship classes of the Japan Maritime Self-Defense Force § SS : Submarine The Netherlands – List of submarines of the Netherlands Pakistan – List of active Pakistan Navy ships § Submarines Poland – List of ships of the Polish Navy § Submarine fleet Romania – Romanian submarines of World War II Russia – List of Soviet and Russian submarine classes, Future Russian submarines Soviet Union – List of ships of the Soviet Navy § Submarines Spain – List of submarines of the Spanish Navy Singapore – Republic of Singapore Navy § Submarines Turkey – List of submarines of the Turkish Navy United Kingdom – List of submarines of the Royal Navy, List of submarine classes of the Royal Navy United States – Submarines in the US Navy, List of submarines of the US Navy, List of US submarine classes, Naval Submarine Medical Research Laboratory

Activated carbon, in 50% w/w combination with celite, is used as stationary phase in low-pressure chromatographic separation of carbohydrates (mono-, di-, tri-saccharides) using ethanol solutions (5–50%) as mobile phase in analytical or preparative protocols. Activated carbon is useful for extracting the direct oral anticoagulants (DOACs) such as dabigatran, apixaban, rivaroxaban and edoxaban from blood plasma samples. For this purpose it has been made into "minitablets", each containing 5 mg activated carbon for treating 1ml samples of DOAC. Since this activated carbon has no effect on blood clotting factors, heparin or most other anticoagulants this allows a plasma sample to be analyzed for abnormalities otherwise affected by the DOACs. Carbon adsorption has numerous applications in removing pollutants from air or water streams both in the field and in industrial processes such as:

Sources: en.wikipedia.org

Supporting material

Thirty-four isotopes of actinium and eight excited isomeric states of some of its nuclides are known, ranging in mass number from 203 to 236. Three isotopes, 225Ac, 227Ac and 228Ac, were found in nature and the others were produced in the laboratory; only the three natural isotopes are used in applications. Actinium-225 is a member of the radioactive neptunium series; it was first discovered in 1947 as a decay product of uranium-233 and it is an α-emitter with a half-life of 10 days. Actinium-225 is less available than actinium-228, but is more promising in radiotracer applications. Actinium-227 (half-life 21.77 years) occurs in all uranium ores, but in small quantities. One gram of uranium (in radioactive equilibrium) contains only 2×10−10 gram of 227Ac. Actinium-228 is a member of the radioactive thorium series formed by the decay of 228Ra; it is a β− emitter with a half-life of 6.15 hours. In one tonne of thorium there is 5×10−8 gram of 228Ac. It was discovered by Otto Hahn in 1906. There are 32 known isotopes of thorium ranging in mass number from 207 to 238. Of these, the longest-lived is 232Th, whose half-life of 1.4×1010 years means that it still exists in nature as a primordial nuclide. The next longest-lived is 230Th, an intermediate decay product of 238U with a half-life of 75,400 years. Several other thorium isotopes have half-lives over a day; all of these are also transient in the decay chains of 232Th, 235U, and 238U. Twenty-nine isotopes of protactinium are known with mass numbers 211–239 as well as three excited isomeric states.

== Mechanism of action == Gliclazide selectively binds to sulfonylurea receptors (SUR-1) on the surface of the pancreatic beta-cells. It was shown to provide cardiovascular protection as it does not bind to sulfonylurea receptors (SUR-2A) in the heart. This binding effectively closes these K+ ion channels. This decreases the efflux of potassium from the cell which leads to the depolarization of the cell. This causes voltage dependent Ca2+ ion channels to open increasing the Ca2+ influx. The calcium can then bind to and activate calmodulin which in turn leads to exocytosis of insulin vesicles leading to insulin release. The mouse model of Maturity-onset diabetes of the young (MODY) diabetes suggested that the reduced gliclazide clearance stands behind their therapeutic success in human MODY patients, but Urbanova et al. found that human MODY patients respond differently and that there was no consistent decrease in gliclazide clearance in randomly selected HNF1A-MODY and HNF4A-MODY patients. Its classification has been ambiguous, as literature uses it as both a first-generation and second-generation sulfonylurea.

=== Gene regulation === ADP-ribosylation can affect gene expression at nearly every level of regulation, including chromatin organization, transcription factor recruitment and binding, and mRNA processing. The organization of nucleosomes is key to regulation of gene expression: the spacing and organization of nucleosomes changes what regions of DNA are available for transcription machinery to bind and transcribe DNA. PARP1, a poly-ADP ribose polymerase, has been shown to affect chromatin structure and promote changes in the organization of nucleosomes through modification of histones.

Sources: en.wikipedia.org

Frequently asked questions

What does the code PT-141 designate?

PT-141 was the internal development code assigned to bremelanotide during preclinical research. Reference sources sometimes index the peptide under the code rather than the generic name. The two terms describe the same molecule.

Is bremelanotide the same compound as melanotan II?

They are related but distinct cyclic peptides. Melanotan II is an earlier and less selective melanocortin analog. Bremelanotide was developed later with a narrower receptor profile and a defined clinical application.

How is the reviewed product administered?

The reviewed product is given by subcutaneous injection using a single-use autoinjector. Administration occurs under prescription supervision. The device delivers one fixed amount per use rather than a measured or adjustable quantity.

How should a lyophilized peptide be stored?

Storage at -20 °C or below is standard for long-term stability. Desiccant and sealed containers limit moisture exposure. Solutions are prepared only when needed.

Network